Stay updated on Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3, indicating a new release.
    Difference
    0.1%
    Check dated 2024-09-04T03:24:45.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.1%
    Check dated 2024-08-13T21:45:46.000Z thumbnail image
  5. Check
    36 days ago
    No Change Detected
  6. Check
    50 days ago
    Change Detected
    Summary
    The website has been updated to version 2.10.0, adding 5 more interventions/treatments and 2 more study numbers, while removing the previous version 2.9.7.
    Difference
    0.4%
    Check dated 2024-07-23T14:00:27.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T07:27:06.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The website now displays the actual last update posted instead of an estimated time, providing users with more accurate information.
    Difference
    0.0%
    Check dated 2024-07-11T00:55:56.000Z thumbnail image
  9. Check
    63 days ago
    Change Detected
    Summary
    A new treatment regimen involving Pembrolizumab, Pemetrexed, and Platinum Chemotherapy has been added, with specific dosing and administration details provided. Additionally, the definition and monitoring of adverse events, as well as the criteria for disease progression assessment, have been updated and presented.
    Difference
    10%
    Check dated 2024-07-10T00:31:15.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial page.